Veradermics, Inc. (MANE)
122.28
+13.46
(+12.37%)
USD |
NYSE |
Oct 19, 16:00
124.00
+1.72
(+1.41%)
After-Hours: 20:00
Veradermics Price to Book Value : 6.275 for Oct. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 19, 2026 | 6.275 |
| October 16, 2026 | 5.584 |
| October 15, 2026 | 5.905 |
| October 14, 2026 | 5.823 |
| October 13, 2026 | 5.966 |
| October 12, 2026 | 6.281 |
| October 09, 2026 | 6.717 |
| October 08, 2026 | 6.498 |
| October 07, 2026 | 5.693 |
| October 06, 2026 | 5.591 |
| October 05, 2026 | 6.100 |
| October 02, 2026 | 5.991 |
| October 01, 2026 | 6.015 |
| September 30, 2026 | 6.221 |
| September 29, 2026 | 6.046 |
| September 28, 2026 | 5.901 |
| September 25, 2026 | 5.982 |
| September 24, 2026 | 5.938 |
| September 23, 2026 | 5.941 |
| September 22, 2026 | 6.062 |
| September 21, 2026 | 5.788 |
| September 18, 2026 | 5.478 |
| September 17, 2026 | 5.577 |
| September 16, 2026 | 5.256 |
| September 15, 2026 | 5.331 |
| Date | Value |
|---|---|
| September 14, 2026 | 5.219 |
| September 11, 2026 | 5.078 |
| September 10, 2026 | 5.036 |
| September 09, 2026 | 5.114 |
| September 08, 2026 | 5.328 |
| September 04, 2026 | 5.055 |
| September 03, 2026 | 5.016 |
| September 02, 2026 | 5.052 |
| September 01, 2026 | 5.004 |
| August 31, 2026 | 5.050 |
| August 28, 2026 | 5.025 |
| August 27, 2026 | 5.224 |
| August 26, 2026 | 5.275 |
| August 25, 2026 | 5.252 |
| August 24, 2026 | 5.052 |
| August 21, 2026 | 5.276 |
| August 20, 2026 | 5.404 |
| August 19, 2026 | 5.708 |
| August 18, 2026 | 5.712 |
| August 17, 2026 | 5.553 |
| August 14, 2026 | 5.784 |
| August 13, 2026 | 5.696 |
| August 12, 2026 | 5.596 |
| August 11, 2026 | 5.591 |
| August 10, 2026 | 5.683 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 34.47 |
| ANI Pharmaceuticals, Inc. | 2.791 |
| Corcept Therapeutics, Inc. | 17.14 |
| Veru, Inc. | 1.388 |
| Johnson & Johnson | 7.193 |
Price to Book Value Related Metrics
| PEG Ratio | -0.1331 |
| Price | 122.28 |
| Earnings Yield | -2.13% |
| Market Cap | 5.109B |
| PEGY Ratio | -0.1331 |